|
|
||||||||||||||
|
|
|||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ASTHMA |
1 Population Pharmacogenetics Group, Biomedical Research Centre, University of Dundee, UK
2 Division of Medicine and Therapeutics, Asthma and Allergy Unit, Ninewells Hospital and Perth Royal Infirmary, University of Dundee, UK
3 Division of Maternal and Child Health Sciences, Childrens Asthma and Allergy Unit, Ninewells Hospital and Perth Royal Infirmary, University of Dundee, UK
Correspondence to:
Correspondence to:
Professor B J Lipworth
Asthma and Allergy Research Group, Division of Medicine and Therapeutics, Ninewells Hospital, Dundee, UK;b.j.lipworth{at}dundee.ac.uk
Background: The homozygous presence of the arginine-16 variant of the ß2 adrenoceptor gene ADRB2 reverses the benefits from the regular use of short acting ß2 agonists in asthmatic adults compared with the homozygous glycine-16 genotype. We studied the effect of this polymorphic variation on asthma exacerbations in children and young adults and its relation to long acting ß2 agonists.
Methods: A cross-sectional survey was undertaken using electronic records, direct interviews, and genotype determination of position 16 and 27 of the ADRB2 gene in DNA from mouthwash samples of 546 children and young asthmatics attending paediatric and young adult asthma clinics in Tayside, Scotland during 20045. The primary outcome measure was asthma exacerbations over the previous 6 months.
Results: There was an increased hazard of asthma exacerbations across all treatment steps of the British Thoracic Society (BTS) asthma guidelines when the homozygous genotypes Arg/Arg and Gly/Gly were compared (OR 2.05, 95% CI 1.19 to 3.53, p = 0.010), particularly in patients treated with salmeterol (OR 3.40, 95% CI 1.19 to 9.40, p = 0.022). The Glu27Gln polymorphism had no significant effect on asthma exacerbations in any treatment group.
Conclusions: The arginine-16 genotype of ADRB2 predisposes to exacerbations in asthmatic children and young adults, particularly in those exposed to regular salmeterol. This may be explained by genotype selective salmeterol induced downregulation and impaired receptor coupling, and associated subsensitivity of the response.
Keywords: asthma; children; polymorphism; salmeterol; ADRB2
This article has been cited by other articles:
![]() |
R H Green and I D Pavord Use of long-acting {beta}2 agonists in arginine-16 homozygous patients with asthma Thorax, June 1, 2008; 63(6): 568 - 569. [Full Text] [PDF] |
||||
![]() |
N. L Metzger, D. R Kockler, and L. A. H. Gravatt Confirmed {beta}16 Arg/Arg Polymorphism in a Patient with Uncontrolled Asthma Ann. Pharmacother., June 1, 2008; 42(6): 874 - 881. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. Sabato, A.-M. Irani, B. L. Bukaveckas, L. B. Schwartz, D. S. Wilkinson, and A. Ferreira-Gonzalez A Simple and Rapid Genotyping Assay for Simultaneous Detection of Two ADRB2 Allelic Variants Using Fluorescence Resonance Energy Transfer Probes and Melting Curve Analysis J. Mol. Diagn., May 1, 2008; 10(3): 258 - 264. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Panebra, M. R. Schwarb, S. M. Swift, S. T. Weiss, E. R. Bleecker, G. A. Hawkins, and S. B. Liggett Variable-length poly-C tract polymorphisms of the {beta}2-adrenergic receptor 3'-UTR alter expression and agonist regulation Am J Physiol Lung Cell Mol Physiol, February 1, 2008; 294(2): L190 - L195. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. E. Moore Exploration of the {beta}2-adrenergic receptor regulatory regions: the next step in the holy grail of asthma pharmacogenetics research Am J Physiol Lung Cell Mol Physiol, February 1, 2008; 294(2): L187 - L189. [Full Text] [PDF] |
||||
![]() |
L. B. Ware Clinical Year in Review III: Asthma, Lung Transplantation, Cystic Fibrosis, Acute Respiratory Distress Syndrome Proceedings of the ATS, September 15, 2007; 4(6): 489 - 493. [Full Text] [PDF] |
||||
![]() |
M. E. Wechsler, J.-A. O. Shepard, and E. J. Mark Case 15-2007 -- A 20-Year-Old Woman with Asthma and Cardiorespiratory Arrest N. Engl. J. Med., May 17, 2007; 356(20): 2083 - 2091. [Full Text] [PDF] |
||||
![]() |
S B Liggett Genetic variability of the {beta}2 adrenergic receptor and asthma exacerbations. Thorax, November 1, 2006; 61(11): 925 - 927. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |